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Abstract
We describe the use of site specific recombination to study the host-parasite interactions of 
Toxoplasma gondii. We present a Toxoplasma strain that efficiently injects a Cre fusion protein 
into host cells. In a Cre-reporter cell line, a single parasite invasion induced Cre-mediated 
recombination in 95% of infected host cells. By infecting Cre reporter mice with these parasites, 
host cell infection could also be monitored in vivo.
Site specific recombination (SSR) is a well established system for genetically modifying 
targeted cells and has been used to spatially and temporally control the expression of 
selected genes. SSR should offer the same advantages to the study of intracellular pathogens 
as it does to the study of developmental or cancer biology1,2. Engineered intracellular 
pathogens that introduce Cre into host cells would permit the use of SSR to examine the 
consequences of removing specific host genes only in the infected cells. We sought to 
extend the use of the Cre-loxP system to studying the host-pathogen interactions of the 
eukaryotic parasite Toxoplasma gondii by creating a Toxoplasma strain that could inject Cre 
into host cells.
Toxoplasma is an obligate intracellular pathogen that has unique organelles – the rhoptries 
and dense granules – that are known to secrete effector proteins into host cells during 
invasion3–5. It is a natural pathogen for mice which thus serve as an excellent model for the 
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study of human infection6,7. Hence, the combination of a Cre-secreting strain of 
Toxoplasma and the many mouse strains that have already been engineered to carry loxP-
flanked (“floxed”) genes represents a powerful tool for studying Toxoplasma-host 
interactions in vitro and in vivo.
A Toxoplasma strain that secretes Cre has been previously described8 but the released Cre 
did not efficiently enter host cells: only 1–2% of infected reporter cells showed evidence of 
Cre-mediated recombination. We engineered a fusion between Cre and toxofilin (Fig. 1a), a 
rhoptry protein3,9 that is introduced into host cells during invasion10. We electroporated 
parental parasites with a plasmid encoding HA-tagged toxofilin-Cre and a separate cassette 
for a drug-selectable marker11, and selected clones by limiting dilution.
We confirmed appropriate organelle targeting of toxofilin-Cre in individual clones by 
immunofluorescence microscopy, for which we co-stained the parasites for HA and ROP2/4, 
a well studied rhoptry protein (Fig. 1b). We established the integrity of the fusion protein by 
probing Western blots of whole parasite lysates using anti-HA antibodies (Fig. 1c) which 
revealed a protein of the appropriate size (~65 kDa). Using anti-toxofilin antibodies, the 
expression level of the fusion protein was found to be approximately equivalent to that of 
the endogenous protein (data not shown). We selected a clone with all of these properties for 
further characterization. We refer to this parasite strain as the SeCreEt (Secreted Cre, 
Epitope-tagged) strain.
To develop Cre-reporter cells, we transduced immortalized mouse fibroblast precursor cells 
with a retrovirus derived from a Cre reporter plasmid (Fig. 2a). The reporter cells 
constitutively express DsRed unless Cre-mediated recombination occurs, in which case 
eGFP is expressed. We isolated clones stably expressing red fluorescent protein (DsRed) by 
fluorescence-activated cell sorting (FACS).
To evaluate the efficiency and time course of Cre-mediated recombination by SeCreEt 
parasites, we synchronously infected Cre reporter cells, fixed the infected cultures at 2, 4, 6, 
10, 18, 24 and 34 hours after infection, and then examined the cells for eGFP expression. 
SeCreEt parasites, but not parental parasites, triggered Cre-mediated recombination leading 
to eGFP expression in infected reporter cells (Fig. 2b,c); staining for the Toxoplasma protein 
SAG-1 was used to confirm infection of cells. In fact, invasion by a single SeCreEt parasite, 
as defined by a single parasitophorous vacuole in the host cell, led to eGFP expression in 
95% ± 2% s.e.m. (n = 3) of infected reporter cells (Fig. 2d) at 24 hours post-infection. In 
addition, we first noted eGFP expression in ~13% of the infected cells at 4 hours post-
infection. As expected, the percentage and intensity of eGFP expression increased over time 
until reaching a plateau at 18–24 hours (Fig 2d). No eGFP expression was seen in reporter 
cells incubated with heat-killed SeCreEt parasites, with the lysate of freeze-thaw ruptured 
SeCreEt parasites, or with media from cultured SeCreEt parasites (data not shown). eGFP 
expression was also not seen in reporter cells transfected with the toxofilin-Cre plasmid, in 
which toxofilin:Cre expression is driven by a Toxoplasma specific promoter (data not 
shown). Overall, these data suggest that live SeCreEt parasites introduce toxofilin-Cre at or 
around the time of invasion and that the fusion protein rapidly and efficiently produces Cre-
mediated recombination in vitro. Interestingly, we also observed a number of eGFP-positive, 
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uninfected cells exclusively in the cultures infected with live SeCreEt parasites. This 
population of cells could be due to some combination of abortive invasion events and cells 
that divided after infection (yielding one infected and one uninfected daughter cell). The 
origin of these cells will require further investigation.
To determine whether the SeCreEt parasites could be used to analyze host-parasite 
interactions in vivo, we utilized a Cre-reporter mouse line that has firefly luciferase in the 
Gt(Rosa)26Sor locus but with a floxed triple polyadenylation site between the firefly 
luciferase-coding region and the promoter12. As a result, luciferase expression should only 
occur after Cre-mediated recombination. We inoculated these mice intraperitoneally with 
live SeCreEt parasites, live parental parasites or a lysate of 3.2 × 106 freeze-thawed SeCreEt 
parasites. We then examined the mice daily by bioluminescence imaging (BLI), as 
previously described13. Infection with live SeCreEt parasites activated the luciferase as early 
as 5 days post infection (dpi) while infection with the parental strain or the freeze-thaw 
lysate never yielded a luciferase signal (Fig. 3 and Supplemenatry Fig. 1 online).
To verify that the majority of the luciferase signal coming from the SeCreEt-infected 
animals was generated from parasite-infected cells, we infected Cre-reporter mice with 
SeCreEt parasites that also expressed mCherry, collected the peritoneal exudate cells 
(PECS) at 7 dpi, and then used FACS to separate infected (mCherry-positive) from 
uninfected cells (mCherry-negative). As anticipated in this acute stage of the disease, the 
FACS indicated that ~60% of the PECS were infected, which we confirmed by using 
fluorescence microscopy to inspect the pre-FACS PECS. We performed quantitative PCR 
on cDNA obtained from infected and uninfected cells, and observed that the infected cell 
population expressed four times the amount of luciferase mRNA compared to the uninfected 
population (see Supplementary Fig. 2 online). The fact that we observe luciferase mRNA 
also in uninfected cells is consistent with the in vitro results described above, and suggests 
that there may also be abortive invasion events and/or division of host cells after infection in 
vivo. Nevertheless, these results clearly indicate that the SeCreEt parasites also function 
effectively in vivo.
There are several advantages to utilizing a secreted Cre-based system to investigate host-
parasite interactions of Toxoplasma. First, Cre mediated recombination leads to a permanent 
change in host cells which is particularly germane for organisms such as Toxoplasma that 
have prolonged latent states. Hence, once activated, the reporter gene will be expressed 
throughout the life of the host cell, allowing for in vivo analysis of latent toxoplasmosis at 
any time point, even months or years, after invasion. Second, SSR allows the detection of 
miniscule amounts of Toxoplasma-derived effector proteins introduced into host cells14. 
Finally, the greatest advantage of the SeCreEt parasites may be their ability to conditionally 
activate or inactivate individual genes only in cells that have had intimate contact with 
Toxoplasma. This circumvents several problems: it allows the study of essential genes, 
deletion of which would otherwise lead to embryonic lethality, it circumvents unknown 
compensatory changes that may result from germline deletions even of non-essential genes, 
and it restricts gene ablation to predominantly infected cells, which would remain 
challenging even in conditional or inducible knockouts. Thus the role of a given host gene in 
the host-parasite interaction can be studied on a cell-by-cell level.
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There are, of course, limitations to this system. First, a small fraction of uninfected cells are 
permanently genetically modified, as described above. Second, 100% in vitro recombination 
efficiency was never achieved, even when we prolonged the length of time after invasion 
and increased the multiplicity of infection to 4 (data not shown). Third, an inevitable lag will 
exist between invasion, excision of the target gene and loss of its pre-existing product 
through decay. Hence, host processes that are launched immediately and irrevocably upon 
invasion (e.g., signals detected by the innate immune system) may not be affected by the 
excision of the triggering gene. Even with these limitations, and in view of the large number 
of existing floxed cell lines and mice, the SeCreEt parasites are a highly efficient system for 
detecting infected host cells and for determining the function of a specific host gene at the 
level of a single infected cell in vitro and in vivo.
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Figure 1. 
SeCreEt parasites. (a) Schematic of the toxofilin-Cre fusion construct. Arrow indicates the 
transcription start. (b) Phase contrast and fluorescence images of SeCreEt parasites stained 
as indicated. Scale bar, 5 μm. (c) Western Blot of lysate from parental strain (RH) or 
SeCreEt strain probed anti-HA antibody. SAG-1 serves as the loading control.
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Figure 2. 
SeCreEt parasites activate eGFP in reporter cell lines. (a) Schematic of the retroviral 
construct used to produce the Cre-reporter cell line. The DsRed and eGFP coding regions 
are driven by a promoter in the long terminal repeat (LTR) but have three stop codons 
separating them, thus preventing expression of eGFP. Arrow indicates transcription start. 
Blue triangles indicated loxP sites and their orientation. SD is splice donor, SA is splice 
acceptor, and Psi (ψ) is a retroviral packaging signal. (b,c) Cre-reporter cells 24 hours after 
infection with parental strain (b) or SeCreEt parasites (c). Panels from left to right: phase, 
red shows both DsRed expression and staining with Toxoplasma-specific anti-SAG1 
antibody, green shows eGFP expression, merge. Scale bars, 5 μm. (d) The percentage of 
SeCreEt parasite-infected Cre-reporter cells that showed eGFP expression is plotted at the 
indicated time points.
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Figure 3. 
Analysis of SeCreEt parasites in vivo. Bioluminescence imaging of Cre-reporter mice with a 
“floxed stop luciferase” after inoculation with the indicated numbers of parental (RH) or 
SeCreEt parasites. Ventral images from 4 to 9 days post-inoculation (dpi) are shown. An 
“X” indicates no further data could be obtained due to death of the animal.
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